title: Oral thyroid hormone pretreatment in left ventricular dysfunction.
authors.affiliation: Cardiovascular Surgery, Ankara University, School of Medicine, Ankara, Turkey. sirlak@hotmail.com
authors.forename: Mustafa
authors.initials: M
authors.lastname: Sirlak
authors.forename: Levent
authors.initials: L
authors.lastname: Yazicioglu
authors.forename: Mustafa Bahadir
authors.initials: MB
authors.lastname: Inan
authors.forename: Sadik
authors.initials: S
authors.lastname: Eryilmaz
authors.forename: Refik
authors.initials: R
authors.lastname: Tasoz
authors.forename: Atilla
authors.initials: A
authors.lastname: Aral
authors.forename: Umit
authors.initials: U
authors.lastname: Ozyurda
mesh_terms: D000284:Administration, Oral; D000368:Aged; D002302:Cardiac Output / Q000187:drug effects; D002316:Cardiotonic Agents / Q000008:administration & dosage; D002496:Central Venous Pressure / Q000187:drug effects; D001026:Coronary Artery Bypass; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D011300:Preoperative Care / Q000379:methods*; D011446:Prospective Studies; D011651:Pulmonary Artery / Q000503:physiopathology; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000097:blood; D016896:Treatment Outcome; D014284:Triiodothyronine / Q000097:blood / Q000627:therapeutic use*; D014655:Vascular Resistance / Q000187:drug effects; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D002316:Cardiotonic Agents; D014284:Triiodothyronine; D013972:Thyrotropin; D013974:Thyroxine; D010100:Oxygen